[Studies on allosamidin and aflastatin, novel inhibitors of important metabolic pathways, from microorganisms].
Shohei
S
Sakuda
D000117:Acetylglucosamine / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology*; D000348:Aflatoxins / Q000096:biosynthesis; D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000302:isolation & purification / Q000494:pharmacology*; D011760:Pyrrolidinones / Q000302:isolation & purification / Q000494:pharmacology*; D014312:Trisaccharides / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology*
D000348:Aflatoxins; D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D011760:Pyrrolidinones; D014312:Trisaccharides; C105377:aflastatin A; C116936:aflastatin B; C054851:allosamidin; D000117:Acetylglucosamine